Treatment of AML cells with pharmacological inhibitors of ATM or siRNA silencing ATM induces relocalization of NFκB from the nucleus to the cytoplasm, resulting in apoptosis of AML cells [54]. The gene discussed is NFKB1; the disease is acute myeloid leukemia.